HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights Medical Device Investing
HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights Medical Device Investing
HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights Medical Device Investing
Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company Life Science Investing
Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company Life Science Investing
Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company Life Science Investing
OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares Life Science Investing
OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares Life Science Investing
OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares Life Science Investing
